Skip to main content

FARALLON CAPITAL MANAGEMENT LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 909661 SAN FRANCISCO, CA

Position in CRNX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$336,372,047
+$33,532,328 QoQ
Shares Held
8,989,098
+7.8% QoQ
Ownership
8.48%
of shares outstanding
% of Portfolio
1.99%
of 13F equity value
Holder Rank
#3
of 266 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FARALLON CAPITAL MANAGEMENT LLC holds $7,178,355,833 across 25 Biotechnology names. CRNX ranks #8 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 CRNX
Crinetics Pharmaceuticals, Inc.
This page
8,989,098 $336,372,047

All Filings in CRNX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $336,372,047 8,989,098
2026-06-30 $336,372,047 8,989,098
2026-03-31 $302,839,719 8,338,098
2025-12-31 $322,735,711 6,933,098
2025-09-30 $240,324,581 5,770,098
2025-06-30 $133,621,778 4,646,098
2025-03-31 $154,454,986 4,605,098
2024-12-31 $208,359,760 4,075,098
2024-09-30 $59,378,200 1,162,000
2024-06-30 $22,260,630 497,000
2024-03-31 $234,050 5,000
2023-12-31 $4,372,924 122,904
2023-09-30 $10,763,024 361,904